17.45
price down icon0.40%   -0.07
 
loading

Grail Inc Stock (GRAL) Latest News

pulisher
Nov 27, 2024

Grail initiated at equal weight by Morgan Stanley (NASDAQ:GRAL) - Seeking Alpha

Nov 27, 2024
pulisher
Nov 27, 2024

Grail (NASDAQ:GRAL) Coverage Initiated by Analysts at Morgan Stanley - MarketBeat

Nov 27, 2024
pulisher
Nov 21, 2024

Golden Grail Beverages Cancels Convertible Debt to Reduce Dilution - Yahoo Finance

Nov 21, 2024
pulisher
Nov 19, 2024

Grail's CFO Aaron Freidin sells $426,937 in common stock By Investing.com - Investing.com South Africa

Nov 19, 2024
pulisher
Nov 19, 2024

Grail's CFO Aaron Freidin sells $426,937 in common stock - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

GRAIL to Participate in Upcoming Investor Conferences - WV News

Nov 19, 2024
pulisher
Nov 19, 2024

Golden Grail Beverages CEO Shares Global Vision in New Interview with SmallCapVoice.com - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

GRAIL to Present at Piper Sandler and Evercore ISI Healthcare Conferences in December | GRAL Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 18, 2024

GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most - Mugglehead

Nov 18, 2024
pulisher
Nov 18, 2024

Grail tests first patient for TROPION-Lung12 Phase 3 study - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

GRAIL Launches FDA-Approved Phase 3 Trial for Breakthrough Lung Cancer Blood Test | AZN Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 18, 2024

(GRAL) Trading Report - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 15, 2024

Wolfe Research Begins Coverage on Grail (NASDAQ:GRAL) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Wolfe starts Grail at Peer Perform on time and money needs - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Grail initiated with a Peer Perform at Wolfe Research - Nasdaq

Nov 15, 2024
pulisher
Nov 14, 2024

Golden Grail Beverages Corp. (OTC: GOGY) Retains SmallCapVoice.com Inc. - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Golden Grail Beverages Slashes Share Count 90%, Plans Strategic Acquisitions for 2025 | GOGY Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

PRIMECAP Management's Strategic Acquisition of GRAIL Inc Shares - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Grail Inc. Reports Strong Galleri Test Growth in Q3 2024 - Nasdaq

Nov 12, 2024
pulisher
Nov 12, 2024

GRAIL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

GRAIL Inc Reports Q3 2024 Revenue of $28.7 Million with Signific - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

GRAIL Reports Third Quarter 2024 Financial Results - PR Newswire

Nov 12, 2024
pulisher
Nov 12, 2024

Quantune joins quest for the holy grail of non-invasive glucose monitoring - TechCrunch

Nov 12, 2024
pulisher
Nov 07, 2024

How to Take Advantage of moves in (GRAL) - Stock Traders Daily

Nov 07, 2024
pulisher
Nov 05, 2024

Grail (GRAL) Scheduled to Post Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PR Newswire

Nov 04, 2024
pulisher
Oct 30, 2024

Jim Cramer says Reddit’s surge is about ‘raw user power,’ calls it ‘holy grail’ for advertisers - CNBC

Oct 30, 2024
pulisher
Oct 29, 2024

GRAIL to Announce Third Quarter 2024 Financial Results - StockTitan

Oct 29, 2024
pulisher
Oct 27, 2024

(GRAL) Trading Advice - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 27, 2024

Google: The Bullish Pivot Before The Earnings Grail (NASDAQ:GOOG) - Seeking Alpha

Oct 27, 2024
pulisher
Oct 25, 2024

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation - The Cancer Letter

Oct 25, 2024
pulisher
Oct 25, 2024

Nike x Wu-Tang Clan Reunite to Release Legendary Sneaker Grail — NIKE, Inc. - Nike

Oct 25, 2024
pulisher
Oct 25, 2024

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Real-world study of Grail’s Galleri consistent with trial data - BioWorld Online

Oct 24, 2024
pulisher
Oct 23, 2024

The Jeff Bezos-backed cancer treatment company is being sold for eight billion dollars - Telegrafi

Oct 23, 2024
pulisher
Oct 23, 2024

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference - PR Newswire

Oct 23, 2024
pulisher
Oct 23, 2024

Health Beat: The 'holy grail' of cancer screening - 69News WFMZ-TV

Oct 23, 2024
pulisher
Oct 23, 2024

CEO & Director Of GRAIL Sold 51% Of Their Shares - Simply Wall St

Oct 23, 2024
pulisher
Oct 22, 2024

Company commits not to try to crack ‘holy grail’ cement-free formula - Irish Independent

Oct 22, 2024
pulisher
Oct 22, 2024

Grail appoints healthcare veteran Sarah Krevans to board By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

Grail appoints healthcare veteran Sarah Krevans to board - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

GRAIL Appoints Sarah Krevans to Board of Directors - Quantisnow

Oct 21, 2024
pulisher
Oct 21, 2024

Layoff Tracker: Takeda Cuts More Employees, Total Exceeds 1,300 in 2024 - BioSpace

Oct 21, 2024
pulisher
Oct 17, 2024

Grail CEO Robert Ragusa sells $1.73 million in stock - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

How the (GRAL) price action is used to our Advantage - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 15, 2024

Health Headlines: Holy Grail of cancer screening - KPLC

Oct 15, 2024
pulisher
Oct 13, 2024

GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now - Insider Monkey

Oct 13, 2024
pulisher
Oct 11, 2024

Grail Inc. executive acquires over $1 million in company stock - Investing.com India

Oct 11, 2024
pulisher
Oct 10, 2024

Grail Inc. executive acquires over $1 million in company stock By Investing.com - Investing.com South Africa

Oct 10, 2024
diagnostics_research LH
$242.15
price up icon 1.43%
$168.45
price up icon 0.08%
$144.36
price up icon 0.99%
diagnostics_research WAT
$386.57
price down icon 0.41%
diagnostics_research MTD
$1,243.40
price up icon 0.90%
$421.76
price up icon 1.06%
Cap:     |  Volume (24h):